Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Chememan Public Company Limited (CMAN.BK)
Bangkok, TH
Based in Bangkok, Thailand, Chememan Public Company Limited functions as a manufacturer and distributor of mineral lime and various chemical commodities. Their product line includes quicklime, hydrated lime, and both raw and finely ground limestone. These lime-based products are essential for a wide range of applications, such as industrial processes, agricultural needs, environmental solutions, and household uses. Beyond manufacturing, the company offers transportation services via dump and tank trucks, alongside comprehensive technical support. Established in 2003, Chememan also extends its reach through the export of its products.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | -2.84% | +7.03% | +3.01% | +15.13% | +16.10% | +21.24% | +16.10% | -0.72% | -28.65% | -28.65% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-4.3% Q1'26: -4.6% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+46.2% ★ Q1'26: +28.6% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+11.7% Q1'26: +13.9% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+14.5% ★ Q1'26: +18.5% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+8.9% ★ Q1'26: +12.4% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×2.95× Q1'26: 2.44× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.20B
est: 2.19B (+0.6%)
|
2.42B
est: 2.47B (-2.0%)
|
2.37B
est: 2.38B (-0.4%)
|
2.24B
est: 2.46B (-8.8%)
|
3.00B
est: 2.51B (+19.5%)
|
3.83B
est: 2.19B (+75.0%)
|
3.66B
est: 2.47B (+48.1%)
|
2.38B
2.38B – 2.38B
-3.6% YoY
|
2.46B
2.46B – 2.46B
+3.1% YoY
|
2.51B
2.51B – 2.51B
+2.3% YoY
|
| EBITDA |
332.78M
est: 404.05M (-17.6%)
|
400.61M
est: 456.92M (-12.3%)
|
262.29M
est: 440.28M (-40.4%)
|
249.55M
est: 453.77M (-45.0%)
|
556.95M
est: 464.31M (+20.0%)
|
869.84M
est: 695.10M (+25.1%)
|
902.12M
est: 786.04M (+14.8%)
|
757.42M
757.42M – 757.42M
-3.6% YoY
|
780.63M
780.63M – 780.63M
+3.1% YoY
|
798.76M
798.76M – 798.76M
+2.3% YoY
|
| EBIT |
172.74M
est: 158.18M (+9.2%)
|
213.32M
est: 178.88M (+19.3%)
|
49.71M
est: 172.36M (-71.2%)
|
-57.22M
est: 177.65M (-132.2%)
|
208.81M
est: 181.77M (+14.9%)
|
496.62M
est: 503.85M (-1.4%)
|
529.34M
est: 569.77M (-7.1%)
|
549.02M
549.02M – 549.02M
-3.6% YoY
|
565.85M
565.85M – 565.85M
+3.1% YoY
|
578.99M
578.99M – 578.99M
+2.3% YoY
|
| Net Income |
109.58M
est: 153.60M (-28.7%)
|
162.63M
est: 163.20M (-0.4%)
|
-2.92M
est: 87.43M (-103.3%)
|
-136.75M
est: 106.95M (-227.9%)
|
98.32M
est: 133.57M (-26.4%)
|
251.63M
est: 153.60M (+63.8%)
|
361.38M
est: 163.20M (+121.4%)
|
87.43M
87.43M – 87.43M
-46.4% YoY
|
106.95M
106.95M – 106.95M
+22.3% YoY
|
133.57M
133.57M – 133.57M
+24.9% YoY
|
| SGA |
667.46M
est: 607.00M (+10.0%)
|
631.08M
est: 686.41M (-8.1%)
|
718.95M
est: 661.42M (+8.7%)
|
787.06M
est: 681.69M (+15.5%)
|
954.53M
est: 697.52M (+36.8%)
|
905.38M
est: 557.91M (+62.3%)
|
875.44M
est: 630.90M (+38.8%)
|
607.93M
607.93M – 607.93M
-3.6% YoY
|
626.56M
626.56M – 626.56M
+3.1% YoY
|
641.11M
641.11M – 641.11M
+2.3% YoY
|
| EPS |
0.16
est: 0.16 (+0.0%)
|
0.18
est: 0.17 (+5.9%)
|
0.00
est: 0.09 (-103.3%)
|
-0.14
est: 0.11 (-225.7%)
|
0.10
est: 0.14 (-28.1%)
|
0.26
est: 0.16 (+62.5%)
|
0.38
est: 0.17 (+123.5%)
|
0.09
0.09 – 0.09
-46.4% YoY
|
0.11
0.11 – 0.11
+22.3% YoY
|
0.14
0.14 – 0.14
+24.9% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-28 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-27 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-26 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-25 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-22 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-21 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-20 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-19 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-18 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-15 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-14 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-13 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-12 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-11 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-08 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-07 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-06 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-05 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-30 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-29 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-28 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-27 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-24 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-23 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-22 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-21 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-20 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-17 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-16 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| L. Chandchutha Chandratat | Chairman & CEO of International | 625.4K | male |
| Adisak Lowjun | Chief Executive Officer, Acting Chief Financial Officer & Director | 459.4K | male |
| Lerssak Boonsongsup | Chief Strategy Officer & Acting Chief People Officer | — | male |
| Pornphen Wiwattanadecha | Vice President of Finance & Accounting | — | female |
| Pree Suvimolthirabutr | Chief Commercial Officer | — | male |
| Sarinthip Yongprawat | Chief Accountant & Vice President of Accounting | — | female |
| Sinaynidh Karitkiat | Company Secretary | — | female |
| Apichai Somboonpakorn | Chief Technology Officer | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for CMAN.BK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
